U.S. Non-English Speakers Less Likely to Have SARS-CoV-2 Test
Seattle study shows non-English speakers less likely to complete testing but more likely to test positive
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Acute Kidney Injury Ups Risk for Death in COVID-19 Patients
Findings based on large study of hospitalized patients in New York City early in the pandemic
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
If it passes final round of human tests, SinoVac will apply to the FDA to sell CoronaVac vaccine
Most People With SARS-CoV-2 Do Not Remain Asymptomatic
Secondary attack rate lower for contacts of people with asymptomatic versus symptomatic infection
Red Blood Cell Distribution Width, Mortality Tied in COVID-19
Elevated RDW and increase in RDW during hospitalization linked to increased mortality risk
Stricter Vaccine Approval Rules Coming From FDA
If approved by the White House, revised guidelines could be released as early as next week
J&J COVID-19 Vaccine Begins Final Stage of Clinical Trials
Phase 3 trials will include 60,000 people and be the largest for a COVID-19 vaccine in the United States
U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States
IHME says COVID-19 is second-leading cause of death in the United States, after heart disease
As Flu Season Approaches, Clinicians Brace for Potential ‘Twindemic’
Reluctance, fear to leave home may impact the amount of people willing to receive the flu vaccine this year, expert tells HD Live!
